[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 4 sources · 4 days · First seen · Last updated

Corporate earnings announcements

Overview

In early August 2026, semiconductor firm Ceva and biopharmaceutical company Mineralys Therapeutics announced the dates for their upcoming Q2 2026 earnings releases, with analysts projecting modest earnings for Ceva and a loss for Mineralys. A few days later, biotech firms Lantheus Holdings and Cellectis reported their first‑quarter results. Lantheus posted earnings that beat expectations and modest revenue growth, while Cellectis posted a loss that narrowly beat consensus forecasts but fell short of revenue expectations. The snapshots together illustrate a brief period in which several publicly traded companies disclosed earnings schedules and then disclosed actual performance, showing a mix of positive beats and modest shortfalls across the sector.

Entities

Lantheus Holdings Inc. · Mineralys Therapeutics · Aldeyra Therapeutics Inc. · Todd C. Brady · Cellectis SA

Timeline

  1. 21 days ago

    [BUSINESS] 3 sources
    Lantheus and Cellectis Report Quarterly Earnings Beats

    Lantheus posted $1.55 EPS beating $1.30 expectations; revenue $388 M. Cellectis posted a $0.22 loss beating a $0.26 loss forecast; revenue $6.9 M. Both companies saw modest stock moves.

  2. 24 days ago

    [BUSINESS] 3 sources
    Ceva and Mineralys Therapeutics Set Q2 2026 Earnings Release Dates

    Ceva will report Q2 2026 earnings on Aug 10, 2026 (expected $0.07 EPS, $28.1 B revenue); Mineralys Therapeutics will report on Aug 11, 2026 (expected loss of $0.55 EPS).

Sources

DigitalMediaNet.com · last10k.com · mommygearest.com · stocknews.com